Crescent Capital BDC, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Crescent Capital BDC, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.51M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $73.65M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $83.84M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $15.54M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $83.63M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $54.67M | Feb 22, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($98.69M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($106.78M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($100.29M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($56.83M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($44.11M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($26.69M) | Feb 22, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.72M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $58.91M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $92.30M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $27.95M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($157.65M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($61.80M) | Feb 22, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.66B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.63B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $1.30B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.32B | Feb 22, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $916.10M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $915.64M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $884.79M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $690.34M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $665.52M | Feb 22, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $706.04M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $740.64M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $742.59M | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $612.54M | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $652.29M | Feb 19, 2025 |
| FY2023 | Dec 31, 2020 | $560.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $406.92M | Feb 22, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($251.03M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($218.50M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($223.34M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($62.50M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($13.91M) | Feb 21, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.04M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $10.13M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $7.78M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $6.40M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $10.07M | Feb 22, 2023 |
| FY2022 | Dec 31, 2020 | $1.75M | Feb 22, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $873.76M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $875.84M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $844.78M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $654.46M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $631.04M | Feb 22, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 22, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 22, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36.97M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 37.06M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 37.06M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 30.89M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 30.89M | Feb 22, 2023 |